The molecular biology of soft-tissue sarcomas and current trends in therapy.

Sarcoma · 2012 · PMC3359746 · PMID 22665999

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

There is a clear trend to consider progression-free survival (PFS) as a more relevant endpoint when assessing the antitumor effects of molecular targeted therapies.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.